Related Experiment Videos

Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms

Coen D A Stehouwer1, Yvo M Smulders

  • 1Department of Medicine, Division of General Internal Medicine, Maastricht University and University Hospital Maastricht, Maastricht, The Netherlands. csteh@sint.azm.nl

Journal of the American Society of Nephrology : JASN
|July 11, 2006
PubMed

Insights

Microalbuminuria signals higher cardiovascular risk in diabetics and non-diabetics. Aggressive risk reduction is advised, though the exact link between microalbuminuria and cardiovascular disease remains unclear.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Microalbuminuria is a significant cardiovascular risk marker.
  • Its presence necessitates intensified cardiovascular risk factor management.
  • The underlying mechanisms linking microalbuminuria to cardiovascular disease are not fully elucidated.

Purpose of the Study:

  • To explore the association between microalbuminuria and cardiovascular disease.
  • To investigate potential causal links or shared risk factors.
  • To identify underlying pathophysiologic processes.

Main Methods:

  • Review of existing studies on microalbuminuria and cardiovascular risk.
  • Analysis of evidence for direct causation between microalbuminuria and atherothrombosis.
  • Evaluation of studies testing common risk factor hypotheses.

Main Results:

  • Microalbuminuria is a strong, independent predictor of cardiovascular risk.
  • No definitive evidence supports microalbuminuria causing atherothrombosis or vice-versa.
  • Studies have not confirmed shared risk factors as the primary explanation.

Conclusions:

  • The association is likely due to common pathophysiologic processes.
  • Potential mechanisms include endothelial dysfunction, inflammation, or increased vascular permeability.
  • Further prospective studies are required to validate these hypotheses.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...